Skip to contentN
National Health Investors Inc
N
NHINational Health Investors Inc Q2 2018 · 10-Q
Revenue$72.96M$72.96M+4.5% vs Q2 2017 Net Income$37.84M$37.84M−1.1% vs Q2 2017 EPS Diluted$0.91$0.91−2.2% vs Q2 2017 Operating Income$37,839,000−1.1% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR
derived
Margins · derivedOperating margin51.9%−2.9 pt vs Q2 2017
Net margin51.9%−2.9 pt vs Q2 2017
ended Jun 30, 2018 · filed Aug 7, 2018 · 38 d after period end